KPT — KP Tissue Share Price
0.000.00%
Last trade - 00:00- CA$80.25m
- CA$80.25m
- 26
- 72
- 44
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.22 | ||
| PEG Ratio (f) | 0.78 | ||
| EPS Growth (f) | 37.09% | ||
| Dividend Yield (f) | 8.97% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.15 | ||
| Price to Tang. Book | 1.15 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | 3.53% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | 2,122.07 | 2,207.93 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +41.47 | +30.43 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KP Tissue Inc. is a Canada-based company, which was created to acquire, and its business is limited to holding, an equity interest in Kruger Products Inc. (Kruger Products). Kruger Products produces, distributes, markets and sells a wide range of disposable tissue products, including bathroom tissue, facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets. The Company operates through two segments: Consumer and AFH. The Consumer segment consists of brands such as Cashmere, Purex, Scotties, SpongeTowels, and Bonterra in Canada and White Cloud in the United States. The AFH segment consists of brands such as Esteem, White Swan, Embassy, and Chalet. The AFH segment consists primarily of the supply of bathroom tissue, facial tissue, paper towels and napkins to commercial users in a variety of industries such as food services, property management, healthcare, manufacturing, education, and lodging.
Directors
- Francois Vimard NEC (59)
- Dino Bianco CEO (59)
- Mark Holbrook CFO
- Gordon Goss SVP
- Michel Manseau SVP
- Susan Irving CMO
- Francois Paroyan GCN
- Louise Wendling DRC
- James Hardy IND
- Michel Letellier IND (56)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 1st, 2012
- Public Since
- December 12th, 2012
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 9,994,203
- Address
- 2 Prologis Blvd., Suite 500, MISSISSAUGA, L5W 0G8
- Web
- https://www.kptissueinc.com/home
- Phone
- +1 9058126936
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for KPT
Q1 2025 KP Tissue Inc Earnings Release
KP Tissue Inc Annual Shareholders Meeting
KP Tissue Inc Annual Shareholders Meeting
Q2 2025 KP Tissue Inc Earnings Release
Similar to KPT
Boyd Services
Toronto Stock Exchange
Knowlton Development
Toronto Stock Exchange
FAQ
What is the KP Tissue share price?
As of Today at 21:38 UTC, shares in KP Tissue are trading at CA$8.03. This share price information is delayed by 15 minutes.
How has the KP Tissue share price performed this year?
Shares in KP Tissue last closed at CA$8.03 and the price had moved by -3.25% over the past 365 days. In terms of relative price strength the KP Tissue share price has underperformed the Toronto Stock Exchange 300 Composite Index by -13.99% over the past year.
What are the analyst and broker recommendations for KP Tissue?
The overall consensus recommendation for KP Tissue is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the KP Tissue dividend yield?
The KP Tissue dividend yield is 8.97% based on the trailing twelve month period.
Does KP Tissue pay a dividend?
Last year, KP Tissue paid a total dividend of CA$0.72, and it currently has a trailing dividend yield of 8.97%. We do not have any data on when KP Tissue is to next pay dividends.
When does KP Tissue next pay dividends?
We do not have data on when KP Tissue is to next pay dividends. The historic dividend yield on KP Tissue shares is currently 8.97%.
How do I buy KP Tissue shares?
To buy shares in KP Tissue you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of KP Tissue?
As of the previous close price of CA$8.03, shares in KP Tissue had a market capitalisation of CA$80.25m.
Where are KP Tissue shares listed?
Here are the trading details for KP Tissue:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: KPT
What kind of share is KP Tissue?
Based on an overall assessment of its quality, value and momentum KP Tissue is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a KP Tissue share price forecast for 2025?
The analyst consensus target price for shares in KP Tissue is CA$8.38. That is 4.36% above the last closing price of CA$8.03.
Analysts covering KP Tissue currently have a consensus Earnings Per Share (EPS) forecast of CA$0.35 for the next financial year.
Find out moreWhat is the trend in the KP Tissue share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like KP Tissue. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -2.88%.
As of the last closing price of CA$8.03, shares in KP Tissue were trading -2.23% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the KP Tissue PE Ratio?
The KP Tissue PE ratio based on its reported earnings over the past 12 months is 21.22. The shares last closed at CA$8.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of KP Tissue?
KP Tissue's management team is headed by:
- Francois Vimard - NEC
- Dino Bianco - CEO
- Mark Holbrook - CFO
- Gordon Goss - SVP
- Michel Manseau - SVP
- Susan Irving - CMO
- Francois Paroyan - GCN
- Louise Wendling - DRC
- James Hardy - IND
- Michel Letellier - IND